ATE247961T1 - Sufentanilhaltige arzneimittel mit verzögerter wirkstoffabgabe - Google Patents

Sufentanilhaltige arzneimittel mit verzögerter wirkstoffabgabe

Info

Publication number: ATE247961T1
Authority: AT; Austria
Prior art keywords: delayed release; products containing; medicinal products; compositions; containing sufentanil
Prior art date: 1996-06-27

Application number

AT97929236T

Other languages

English (en)

Inventor

Kathleen Marie Jeanne Vlaminck

Marc Karel Jozef Francois

Christiane Gabriella Ger Heyns

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-06-27

Filing date

1997-06-19

Publication date

2003-09-15

1997-06-19 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

1997-06-19 Priority claimed from PCT/EP1997/003236 external-priority patent/WO1997049402A1/en

2003-09-15 Application granted granted Critical

2003-09-15 Publication of ATE247961T1 publication Critical patent/ATE247961T1/de

Links

GGCSSNBKKAUURC-UHFFFAOYSA-N sufentanil Chemical compound C1CN(CCC=2SC=CC=2)CCC1(COC)N(C(=O)CC)C1=CC=CC=C1 GGCSSNBKKAUURC-UHFFFAOYSA-N 0.000 title abstract 2
229960004739 sufentanil Drugs 0.000 title abstract 2
230000003111 delayed effect Effects 0.000 title 1
229940126601 medicinal product Drugs 0.000 title 1
239000000203 mixture Substances 0.000 abstract 3
241001465754 Metazoa Species 0.000 abstract 2
208000002193 Pain Diseases 0.000 abstract 1
208000004550 Postoperative Pain Diseases 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
238000007918 intramuscular administration Methods 0.000 abstract 1
238000013268 sustained release Methods 0.000 abstract 1
239000012730 sustained-release form Substances 0.000 abstract 1

Landscapes

Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT97929236T 1996-06-27 1997-06-19 Sufentanilhaltige arzneimittel mit verzögerter wirkstoffabgabe ATE247961T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP96201782		1996-06-27
PCT/EP1997/003236 WO1997049402A1 (en)	1996-06-27	1997-06-19	Sustained release sufentanil compositions

Publications (1)

Publication Number	Publication Date
ATE247961T1 true ATE247961T1 (de)	2003-09-15

Family

ID=27798987

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT97929236T ATE247961T1 (de)	1996-06-27	1997-06-19	Sufentanilhaltige arzneimittel mit verzögerter wirkstoffabgabe

Country Status (4)

Country	Link
AR (1)	AR007625A1 (de)
AT (1)	ATE247961T1 (de)
CA (1)	CA2231732A1 (de)
DE (1)	DE69724435D1 (de)

1997
- 1997-06-19 AT AT97929236T patent/ATE247961T1/de not_active IP Right Cessation
- 1997-06-19 DE DE69724435T patent/DE69724435D1/de not_active Expired - Lifetime
- 1997-06-19 CA CA002231732A patent/CA2231732A1/en not_active Abandoned
- 1997-06-26 AR ARP970102821A patent/AR007625A1/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
AR007625A1 (es)	1999-11-10
DE69724435D1 (de)	2003-10-02
CA2231732A1 (en)	1997-12-31

Similar Documents

Publication	Publication Date	Title
FI973828A0 (fi)	1997-09-29	Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
DE69922964D1 (de)	2005-02-03	Ranolazinhaltige arzneimittel mit verzögerter wirkstoffabgabe
DE69910230D1 (de)	2003-09-11	Paclitaxel enthaltende arzneimittel
NO962088D0 (no)	1996-05-22	Preparat for in vivo-produksjon av terapeutiske produkter
ZA981132B (en)	1999-10-19	Methods, compositions and articles for reducing or preventing the effects of inflammation.
EP0828485A4 (de)	1998-12-02	Verwendung des r-enantiomeren von n-propargyl-1-aminoindan,dessen salze und zusammensetzungen
HUP0104795A3 (en)	2002-05-28	Azabicycloalkanes as ccr5 modulators, pharmaceutical compositions comprising thereof and their use
NL300258I1 (nl)	2007-04-02	Farmaceutische samenstelling voor toepassing in debehandeling van diabetes.
DE69723303D1 (de)	2003-08-07	Arzneimittel mit verzögerter wirkstoffabgabe
AU3136897A (en)	1997-12-09	Compositions, methods and devices for the transdermal delivery of drugs
IL150224A0 (en)	2002-12-01	Lipopeptides and pharmaceutical compositions containing the same
GB2365772A (en)	2002-02-27	Factor
IL127441A (en)	2003-02-12	Substituted pyridines, pharmaceutical compositions comprising them and their use in the preparation of anti-inflammatory medicaments or as selective cyclooxygenase-2 inhibitors
AU2003297260A1 (en)	2004-06-03	Fast-disintegrating solid dosage forms being not friable and comprising pullulan
IL150223A0 (en)	2002-12-01	Lipopeptides and pharmaceutical compositions containing the same
HUP0105003A2 (en)	2002-06-29	2-oxy-4h-3,1-benzoxazin-4-one derivatives, their use and pharmaceutical compositions containing them
IL110481A0 (en)	1994-10-21	1-Benzenesulfonyl-1,3-dihydro-2h-benzimidazol-2-one derivatives, their preparation and pharmaceutical compositions containing them
PL366855A1 (en)	2005-02-07	Combination preparations of aryl substituted propanolamine derivatives with other active ingredients and the use thereof
HUP0202781A3 (en)	2003-10-28	Betha-carboline particulate form, pharmaceutical compositions containing it, their preparations and their use
ATE287264T1 (de)	2005-02-15	Oral anzuwendende buprenorphinhaltige arzneimittel
IL141080A0 (en)	2002-02-10	Disubstituted maleimide derivatives and pharmaceutical compositions containing the same
ZA200007415B (en)	2002-04-02	Amino acid derivatives and drugs containing the same as the active ingredient.
EE9900162A (et)	1999-12-15	Rinnavähi vältimise meetod, farmatseutiline preparaat ja toode ning toimeaine kasutamine
ZA9711734B (en)	1998-06-25	Novel farnesyl transferase inhibitors, their preparation, the pharmaceutical compositions which contain them and their use in the preparation of medicaments.
SE9802937D0 (sv)	1998-09-01	Novel compounds

Legal Events

Date	Code	Title	Description
2004-02-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties